News about Neuroendocrine Cancer Expert Physicians

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Dr. Edward M. Wolin Named Co-Medical Director and Board member of the Carcinoid Cancer Foundation

Dr. Edward M. Wolin

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has been named Director of the Center for Carcinoid and Neuroendocrine Tumors at The Mount Sinai Hospital in New York City, effective March 26, 2018. Dr. Wolin will be joining Michelle Kang Kim, MD, PhD, Associate Professor of Medicine, Gastroenterology, and Associate Director of the Center, and all the physicians comprising the renowned multidisciplinary NET team at Mount Sinai. Dr. Wolin will see patients at Mount Sinai beginning in the spring of 2018 and will bring with him multiple new treatment options and clinical trials.

Matthew Kulke, MD will be a guest speaker for the New England Carcinoid Connection Conference, June 8, 2012

Dr. Matthew H. Kulke

Matthew H. Kulke, MD, has been appointed Chief of Hematology/Oncology and Deputy Cancer Center Director at Boston University/Boston Medical Center, effective March 1, 2018. Dr. Kulke plans to maintain a clinical practice and research focus on neuroendocrine tumors in his new position.  Information about contacting Dr. Kulke for appointments will follow soon.

Dr. Yi-Zarn Wang

Yi-Zarn Wang, DDS, MD, has been named Chairman of the Neuroendocrine Tumor Research Center at the Sammons Cancer Center, Baylor University Medical Center, Department of Surgery, Division of Surgical Oncology, in Dallas, Texas, effective January 8, 2018. Dr. Wang anticipates seeing his first patients at Baylor later this month. Patients interested in contacting Dr. Wang can reach him by email at or at His new phone numbers are 972-817-6080 and 972-817-6081, and his fax number is 972-817-6090.

Stanford University School of Medicine in California has established a new one-year Neuroendocrine Tumor (NET) Fellowship under the direction of NET expert Pamela L. Kunz, MD, who is Director of  the Stanford Neuroendocrine Tumor Program and a Board Member of the North American Neuroendocrine Tumor Society (NANETS).  Applicants for the NET fellowship must have completed one of the following:

Dr. Pamela L. Kunz

  • ACGME-certified fellowship in Hematology and/or Oncology
  • ACGME-certified residency or fellowship in Nuclear Medicine
  • ACGME-certified residency in Surgery

The deadline to apply for the fellowship is January 31, 2018.

For more information on how to apply, click here:

Print Friendly, PDF & Email